Q3 2026
Oct 23, 2026
Shares fell 1.2% after earnings, a roughly flat reaction. Results showed revenue and operating-income growth, but ZYN’s U.S. shipment growth was 4%—13% excluding September 2025 promotions—and management said full-year HTU shipment growth would be slightly below adjusted IMS growth.
Key takeaways
- Q3 organic net revenue grew 7.1% to $11.4 billion; adjusted operating income rose 10.5% organically.
- Adjusted diluted EPS increased 5.4% to $2.36, with growth reduced by about 4 percentage points due to an unfavorable comparison with the prior-year tax rate.
- Smoke-free shipments rose 2.7% in Q3; IQOS HTU shipments were 41.5 billion units. For the full year, the company expects high-single-digit growth in smoke-free adjusted IMS volumes and shipments, while HTU shipment growth is expected to trail adjusted IMS growth slightly.
- ZYN shipment growth was 4% in the U.S., or 13% excluding September 2025 promotional activity; international growth accelerated. VEEV shipments grew 62%.
- Combustibles delivered stable volumes and high-single-digit pricing, with management citing a specific benefit from distribution-term restructuring in certain markets.
Q2 2026
Jul 25, 2026
Philip Morris International's shares rose modestly by 1.6% post-earnings, reflecting a generally stable quarter with solid top-line and profit growth but lacking enough upside to drive a stronger market reaction.
Key takeaways
- Q2 organic net revenue grew +7.6%, driven by strong international Smoke-Free Products and favorable combustible dynamics.
- Adjusted diluted EPS increased +15% to $2.20, supported partly by a favorable currency impact and timing of commercial investments.
- Smoke-free shipments advanced +7.5% in Q2, led by IQOS and e-vapor products (+55%), while oral smoke-free volumes declined slightly (-1.2%).
- Combustible products outperformed expectations with volume growth, pricing, stable share, and gross profit gains, though management cautions this strength may not persist at the same scale.
- U.S. market showed sequential improvement but nicotine pouch volumes (ZYN) grew only modestly (+2%) amid competitive pressures and inventory dynamics.
Q1 2026
Apr 22, 2026
PMI delivered a resilient Q1 with 9% revenue growth driven by strong smoke-free performance, pricing power, and cost management, despite challenging industry volume trends.
Key takeaways
- International smoke-free business achieved nearly 12% volume growth, with IQOS and ZYN contributing significantly to high single-digit organic top-line expansion.
- Adjusted EPS rose 16% to $1.96, supported by favorable currency effects and solid operational execution.
- Total revenues surpassed $10 billion, up 9%, with organic growth of 2.7%, outperforming flat expectations amid U.S. and combustibles headwinds.
- Smoke-free shipments up 9.1%, with notable growth in HTU and e-vapor offsetting oral smoke-free declines; smoke-free volume increased 11%.
- Cigarette volumes declined more than expected at the high end of estimates, influenced by industry declines, excise taxes, and illicit consumption, with expectations of moderation over the coming quarters.
Q3 2025
Oct 21, 2025
Philip Morris International reported robust Q3 results, achieving record smoke-free gross profit exceeding $3 billion and a 17% increase in adjusted diluted EPS to $2.24, driven by strong growth in its global smoke-free business.
Key takeaways
- Smoke-free product volume growth accelerated to 16.6% in Q3, significantly outpacing the global market.
- Adjusted operating income rose 7.5% organically to $4.7 billion, with an adjusted operating income margin expansion of 120 basis points.
- The launch of IQOS in Taiwan and continued expansion into 100 markets underscores a strong commitment to geographic growth.
- Combustibles demonstrated resilience with better-than-expected volumes, particularly in Turkey and Egypt, contributing positively to overall financial performance.
- Year-to-date organic net revenue growth reached 7.5%, aligning with mid-term growth targets despite the temporary impact from Indonesia.